1-Ethylpiperazine → 4-[(4-Ethyl-1-piperazinyl)methyl]-1-piperidinecarboxylic acid, 1,1-dimethylethyl ester
반응식
[CH2:1]([N:3]1[CH2:8][CH2:7][NH:6][CH2:5][CH2:4]1)[CH3:2].[CH:9]([CH:11]1[CH2:16][CH2:15][N:14]([C:17]([OH:19])=[O:18])[CH2:13][CH2:12]1)=O>>[CH2:1]([N:3]1[CH2:8][CH2:7][N:6]([CH2:9][CH:11]2[CH2:16][CH2:15][N:14]([C:17]([O:19][C:11]([CH3:16])([CH3:12])[CH3:9])=[O:18])[CH2:13][CH2:12]2)[CH2:5][CH2:4]1)[CH3:2]참가 물질
3
실험 절차
In operating analogously to preparation LXXIII, starting with N-ethylpiperazine and the t-butyl ester of 4-formyl-1-piperidinecarboxylic acid, the product sought after is obtained as a colourless oil (yield=78%).
후처리
- customIn operating analogously to preparation LXXIII
출처 및 근거
- ORD 기록
- ord-828ff378b40d4d1ebf37dbff17c36249
- 출처 데이터셋
- uspto-grants-2009_05
- 특허 번호
- US07538111B2
반응 노트
불러오는 중…